|

Lorigerlimab Clinical Trials

1 actively recruiting trial across 1 location

▼ -1 trial since May 2026

Also known as: MGD019

Pipeline

Phase 2: 1

Top Sponsors

  • MacroGenics1

Indications

  • Clear Cell Adenocarcinoma of Peritoneum1
  • Clear Cell Adenocarcinoma of Fallopian Tube1
  • Clear Cell Adenocarcinoma of Uterus1
  • Clear Cell Adenocarcinoma of Cervix1
  • Clear Cell Adenocarcinoma of Vagina1

Los Angeles, California1 trial

A Study of Lorigerlimab in Participants With Advanced Solid Tumors

UCLA

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.